Message 4: “Guard against accidental poisoning”
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2008, Vol 25, Issue 1
Abstract
Poisoning is the third commonest cause of unintentional injury death in the European Union. In 2000, an estimated 315 000 people worldwide died as a result of unintentional poisoning. This paper presents (a) the magnitude and the socio-economic burden of this epidemic in the countries of the European Union (EU) Region, (b) the risk factors that are associated with this type of injuries and (c) the evidence based preventive practices that reduce the likelihood of poisoning occurrence. Some of these measures are therefore included in the European Code Against Injuries aiming to raise public awareness regarding injury prevention. Although poisoning involves all age groups, children under the age of 5 and older people above the age of 65 are at greater risk; thus a particular attention has been given to these two age groups.
Authors and Affiliations
D. KENDRICK
Keywords
Related Articles
- EP ID EP134064
- DOI -
- Views 93
- Downloads 0
Comparison of costs of hemoglobin A1c determination by point-of-care testing (POCT) and standard hemoglobin A1c analyzer
OBJECTIVE The use of the levels of hemoglobin A1c for the monitoring of glycemic control in patients with diabetes mellitus (DM) is an accepted method of clinical usefulness. A study was performed to assess the relative...
Acute basophilic leukemia
A 71-year-old man with a 1-year history of fatigue, weakness, recurrent cutaneous plaques and severe bone pain mainly along the spine (lumbar region and shoulders bilaterally) was admitted to our Department. Laborator...
Multiple myeloma-induced Fanconi syndrome with proximal renal tubular acidosis (type II)
No abstract available
Local corticosteroid injections in everyday clinical practice
Local injections of corticosteroids are widely used for the treatment of a variety of musculoskeletal problems. They can be given intra-articularly, periarticularly or into soft tissues. Despite their widespread use, the...
Τhe development of chemotherapy for advanced Hodgkin lymphoma
During the past 50 years the treatment of Hodgkin lymphoma (HL) has pioneered the field of chemotherapy in oncology. Today more than 90% of patients with early stage HL and 80−85% of those with advanced disease can be ul...